Philippe Billiald

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Tissue Engineering

Combination Therapy

Atrial Fibrillation

Top Venues

Journal of clinical pharmacology

Acticor Biotech

Université Pierre et Marie Curie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Acticor Biotech Nov 26 2013

France

Scientific advisor

University of Paris-Sud Sep 01 2008

France

Professor of Biochemistry :: School of Pharmacy

Université de Tours

France

Lecturer / Professor

University of Oxford

United Kingdom

Post-Doc :: Sir William DunnScool of Pathology

Education History

Université Pierre et Marie Curie

France

PHD :: Biochemistry

Publications

Philippe Billiald, Alexandre Stephane Slater, Martin Welin, Joanne C Clark, Stéphane Loyau, Martine Pugnière, Isabella Gizzi Jiacomini, Nadia Rose, Kristell Lebozec, Elie Toledano, Deborah François, Stephen P Watson, Martine Jandrot Perrus
Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition. Blood advances (2022)
Sabrina Karim-Silva, Alessandra Becker-Finco, Isabella Gizzi Jiacomini, Fanny Boursin, Arnaud Leroy, Magali Noiray, Juliana de Moura, Nicolas Aubrey, Philippe Billiald, Larissa M Alvarenga
Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential. Toxins 12 (4) (2020)
Lionel Renaud, Kristell Lebozec, Christine Voors-Pette, Peter Dogterom, Philippe Billiald, Martine Jandrot Perrus, Yannick Pletan, Matthias Machacek
Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation. Journal of clinical pharmacology 60 (9) (2020)